Effects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusions

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

Bernard J. Scallon · Cytokine · 1995 · 682 citations

Life Sciences, Immunology, Molecular Biology +12

Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve‐month randomized, double‐blind, placebo‐controlled trial

Mark Quinn, Philip G. Conaghan, Philip O’Connor et al. · Arthritis & Rheumatism · 2005 · 533 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

Shigeaki Ohno, Satoshi Nakamura, Sadao Hori et al. · PubMed · 2004 · 341 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open‐label trial

İlknur Tuğal-Tutkun, Abdulbaki Mudun, Meri Urgancıoğlu et al. · Arthritis & Rheumatism · 2005 · 307 citations

Medicine, Ophthalmology, Pharmacotherapy +15

Differential Effectiveness of Etanercept and Infliximab in the Treatment of Ocular Inflammation

Anat Galor, Víctor Pérez, Jeffrey Hammel et al. · Ophthalmology · 2006 · 210 citations

Medicine, Immunology, Pharmacotherapy +14